Evaluation of osseointegration of dental implants coated with collagen, chondroitin sulphate and BMP-4: an animal study.

Various studies have shown type I collagen (coll) to increase bone-implant contact (BIC) compared to uncoated implants. The aim of this animal study was to test whether the integration of chondroitin sulphate (CS) and the growth factor rhBMP-4 into a collagenous coating could further increase the measured BIC compared to collagen coated implants alone. The experimental implants had two recesses along the length axis. 120 implants with the surface modifications: coll, coll/CS, coll/CS/rhBMP-4 were inserted into the mandible of 20 minipigs. Six months after implantation, BIC was measured histomorphometrically on the surface and within the recesses. Due to the specific animal model and strict criteria in placement, 39.2 % of the implants were considered as failure and not included in the analysis. Of the successfully gained 73 implants, the highest percentage of BIC was obtained for coll/CS (40%), followed by coll (30%) and coll/CS/rhBMP-4 (27%), P=0.013. BIC within the recesses was highest for coll/CS (51%), followed by coll (43%) and coll/CS/rhBMP-4 (34%), P=0.025. The result suggests that the inclusion of CS slightly increases the BIC compared to collagen coated implants. The further inclusion of a low amount rhBMP-4 had a detrimental effect on bone formation compared to coll/CS, P<0.05.

Induction of cross-links in corneal tissue.

The aim of this study was to investigate the possibility of induction of cross-links in corneal tissue in order to increase the stiffness as a basis for a future conservative treatment of keratectasia. Collagenous biomaterials can be stabilized by chemical and physical agents. The epithelium of enucleated porcine eyes was removed. Eight test groups, 10 eyes each, were treated with UV-light (lambda=254 nm), 0.5% riboflavin, 0.5% riboflavin and UV-light (365 nm) blue light (436 nm) and sunlight, and the chemical agents-glutaraldehyde (1% and 0.1%, 10 min) and Karnovsky's solution (0.1%, 10 min). Strips of 5 mm in width and 9 mm in length were cut from each cornea and the stress-strain behaviour of the strips was measured to assess the cross-linking process. For comparison, ten untreated corneas were measured by the same method. Compared to untreated corneas treatment with riboflavin and UV-irradiation as well as weak glutaraldehyde or Karnovsky's solutions resulted in an increased stiffness of the cornea. The biomechanical behaviour of the cornea can be altered by glutaraldehyde, Karnovsky's solution, and with riboflavin and UV-irradiation which offers the potential of a conservative treatment of keratoconus. To optimize this effect further investigation is necessary regarding the dose-response and in-vivo application.

[Increased rigidity of the cornea caused by intrastromal cross-linking]. / Erhöhung der Festigkeit der Hornhaut durch Vernetzung.

PURPOSE: To increase the stability of the cornea by artificial cross-linking (radiation or chemical agents) and to investigate a future therapy for keratoconus. MATERIALS AND METHODS: The epithelium of enucleated porcine eyes was removed. Ten eyes in each of eight test groups were treated with UV light (lambda = 254 nm), 0.5% riboflavin and UV light (365 nm), blue light (436 nm) and sunlight, and the chemical agents glutaraldehyde (1% and 0.1%, 10 min) and Karnovsky's solution (0.1%, 10 min). Strips of 5 mm in width and 9 mm in length were cut from each cornea and the stress-strain behaviour of the strips was measured. For comparison, eight groups of ten untreated corneas each were measured by the same method. RESULTS: Compared to untreated corneas riboflavin and UV irradiation as well as glutaraldehyde and Karnovsky's solution treatment resulted in significantly increased stiffness of the cornea (p < 0.05). CONCLUSIONS: The biomechanical behaviour of the cornea can be altered by low-concentration glutaraldehyde, Karnovsky's solution, and by riboflavin and UV irradiation, which offers potential conservative treatment of keratoconus. To optimize this effect further investigation is necessary regarding the dose-effect relation and the in-vivo conditions.